This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Devalued and distrusted: Can the pharmaceutical industry restore its broken image?

December 10th, 2012

Devalued and Distrusted: Can the Pharmaceutical Industry Restore Its Broken Image? offers a balanced view of the role of drug discovery in improving public health.

The author, former Pfizer president John LaMattina addresses the progress that industry has made in improving its abilities to measure both risk and benefits of its new medicines, and then tackles the issue of R&D productivity—the reasons for the drop-off, and how the industry can rehabilitate its image.

Devalued and Distrusted is intended to provide patients, physicians, regulators, and payers with an appreciation of these issues as well as the value that pharmaceutical R&D adds to society.

More information:
Devalued and Distrusted: Can the Pharmaceutical Industry Restore Its Broken Image?
December 2012, 128pp
978-1-1184-8747-1
$22.95; CAN $32.95; €24.60; £20.25

Provided by Wiley

Citation: Devalued and distrusted: Can the pharmaceutical industry restore its broken image? (2012, December 10) retrieved 15 January 2025 from https://sciencex.com/wire-news/116602764/devalued-and-distrusted-can-the-pharmaceutical-industry-restore.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.